RetiSpec
Geospatial AI · Earth Observation
Overview
RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye.
Funding and backers
Total raised
$10M
1 round on record
Latest round
$10M
Series A · Jul 2024 · 2 yr ago
Team
51-200
employees, estimated range
Backers
1
iGan Partners
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 26, 2024
Raised a round Series A $10M · PRNewswire
Aug 2016
Website went live first capture in the Wayback Machine
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Jul 2024 | $10M | — | PRNewswire |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Traditional hyperspectral imaging solutions are difficult to use. They provide data that is hard to interpret and often non-actionable…
Discover hyperspectral imaging and Earth observation data from Wyvern. Access research-grade satellite imagery that reveals the hidden…
ImagoAI is revolutionizing the food testing industry by using Hyperspectral Imaging and AI to test mycotoxins in under 30 seconds.
An AI-powered total vision system for perception, learning, and action with real-time RGB, polarized, and hyperspectral sensing.
Lumeria is an at-home skin tracker and longitudinal skin monitoring device that fuses the multispectral imaging clinics use with AI to…
Active patent portfolio covering U.S., international, and PCT jurisdictions Disrupting $40B+ compact camera module market Creating new…
Financials
Total raised
$10M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2024 | $10M | Details |
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
iGan PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
RetiSpec secures $13.8 million to detect Alzheimer's early through retinal imaging
The round brings in Eli Lilly and Topcon Healthcare as strategic investors.
Read more
Report
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer
/PRNewswire/ - RetiSpec Inc., an innovator in AI-driven eye diagnostics for brain health, announced the successful closing of its $10M USD Series A financing....
Read more
Report
RetiSpec,Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
/PRNewswire/ - RetiSpec, Inc., an innovator in AI-powered eye diagnostics for brain health, and Topcon Healthcare, Inc. a leading provider of medical devices...
Read more
Report
Retispec develops noninvasive early Alzheimer's diagnostic
As attention turns to new drugs that can address the growing burden of Alzheimer's disease (AD) in an aging global population, Retispec Inc. has developed a noninvasive test that may be able to detect early signs of the neurodegenerative disease decades b
Read more
Report
RetiSpec leveraging University of Minnesota tech to detect earlier-stage Alzheimer's
The collaboration and licensing agreement will allow the company to further develop technology for early detection of Alzheimer's disease.
Read more
Report